The stock rose 14.8% following Q1 results, driven by better-than-expected sales and earnings per share despite ongoing pressure in underlying business trends. Investor enthusiasm appears tied to early signs of success from the company’s innovation and brand revitalization strategy, with confidence growing in long-term transformation plans.
Bath & Body Works reported Q4 2025 results with net sales down 2% and adjusted EPS of $2.05, outperforming expectations, but still highlighting the need for continued strategic improvements via the new Consumer First Formula.
Bath & Body Works, Inc. reported disappointing third-quarter results, with management acknowledging the need for a comprehensive strategy overhaul to reignite growth and reclaim relevance in a competitive environment.